Alberto Realuyo joined Convergence Healthcare Advisors in 2014, bringing over 18 years of M&A experience, with an exclusive focus on healthcare M&A for the past six years. Mr. Realuyo brings world class strategic advisory experience to Convergence with an expertise in selling companies both large and small.
Alberto was most recently Senior Director, Healthcare M&A at Deutsche Bank where he executed various landmark strategic sale transactions in the healthcare sector including the sale of Life Technologies to Thermo Fisher ($15.8 billion); the sale of Warner Chilcott to Actavis ($8.5 billion); the sale of Medicis to Valeant ($2.6 billion); and the sale of Cephalon to Teva ($6.8 billion). While at Deutsche Bank, Alberto often served as the M&A partner supporting the banking coverage efforts of his current partners, Bryan Lookatch and Ananth Bhogaraju when both were also with Deutsche Bank.
Prior to Deutsche Bank, Mr. Realuyo worked in the M&A departments of Salomon Brothers (now Citi) and Lazard Freres, and Fredericks Michael & Co., a middle-market advisory firm focused on cross border M&A
Mr. Realuyo holds an MBA for IESE Business School (Barcelona, Spain) and an AB from Dartmouth College.